if thats true i hope they revisit that, you cant beat recurring revenue. i would also like them to look at pay per use.
i cant see why Australia needs to be different to the states especially if the tests are covered by Medicare (is it?)
Ann: New Clinical Practice Guidance Recommends Use of BIS, page-62
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
-0.002(3.13%) |
Mkt cap ! $125.4M | |||
| Open | High | Low | Value | Volume |
| 6.4¢ | 6.4¢ | 6.2¢ | $81.96K | 1.304M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1383934 | 6.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.3¢ | 49348 | 3 |
View Market Depth
| Last trade - 12.20pm 30/07/2024 (20 minute delay) ? |
| IPD (ASX) Chart |